BioSpace News Archive

Deals

SI-BONE Announces Pricing of Public Offering of Common Stock - Oct 15, 2020

SI-BONE, Inc. announced the pricing of its underwritten public offering of 3,190,053 shares of its common stock at a price to the public of $22.00 per share.

October 14, 2020
·
3 min read
Urodynamics Equipment and Disposables Market: Increase in Demand for Advanced and Safe Urodynamics Equipment to Boost Global Market

According to the report, the global urodynamics equipment and disposables market was valued at US$ 196.5 Mn in 2019 and is projected to reach US$ 386 Mn by 2030, expanding at a CAGR of ~6% from 2020 to 2030.

October 14, 2020
·
5 min read
Oncology Companion Diagnostic Market | Economic Benefits Offered by the Assay to Shoot Up its Demand in the Market

Companion diagnostics are developed along with drugs so as to assist in the exclusion or selection of groups for the purpose of treating patients with a certain drug, based on biological characteristics of the selected pool of patients.

October 14, 2020
·
4 min read
Impact of COVID-19 on Healthcare E-Commerce Market

The demand within the global healthcare e-commerce market is growing on back of continuous advancements in the e-commerce industry and online sales of medication.

October 14, 2020
·
5 min read
Bipolar Forceps Market | Growth Parameters and the Potential Opportunities in Key Product Segments

Bipolar forceps have been extensively utilized in electrosurgery. In particular, nonstick bipolar forceps have seen widespread interest among surgeons for different specialties.

October 14, 2020
·
4 min read
Drug Development

Aliqopa™ (copanlisib) in Combination With Rituximab Meets Primary Endpoint in Patients With Relapsed Indolent Non-Hodgkin’s Lymphoma

Phase III study CHRONOS-3 in patients with relapsed indolent Non-Hodgkin’s Lymphoma (iNHL) who have received one or more prior lines of rituximab-containing therapy meets primary endpoint of progression-free survival

October 14, 2020
·
12 min read
Biotech Bay

Rentschler Biopharma and ATUM Announce Leap-In Transposase® Licensing Agreement for Development of Robust Manufacturing Processes for Complex Therapeutic Proteins

License agreement provides Rentschler Biopharma full access to ATUM’s Leap-In Transposase® cell line development (CLD) tools

October 14, 2020
·
5 min read
Biotech Bay

Terns Pharmaceuticals to Present Positive Data on Single-Agent and Combination NASH Programs at The Liver Meeting® Digital Experience 2020

Terns Pharmaceuticals, Inc. announced that four abstracts detailing both clinical and preclinical data for multiple non-alcoholic steatohepatitis programs within the company’s portfolio were accepted for presentation at The Liver Meeting™ Digital Experience 2020, taking place November 13-16, 2020.

October 14, 2020
·
6 min read
Genetown

Dyno Therapeutics Enters Collaboration and License Agreement With Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies

Collaboration combines Dyno’s AI-powered AAV vector capabilities with Roche and Spark Therapeutics’ leading-edge gene therapy capabilities

October 14, 2020
·
4 min read
Drug Development

Evelo Biosciences Completes Enrollment in Phase 1b Clinical Trial Cohort Evaluating EDP1815 in Atopic Dermatitis–Data expected in 1Q 2021

Evelo Biosciences, Inc., a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, announced that it has completed enrollment of 24 patients in the Phase 1b clinical trial cohort evaluating EDP1815 in mild to moderate atopic dermatitis.

October 14, 2020
·
8 min read